ARD-101

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861AARDPhase 3Terminated2026-05-07Actual
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034AARDPhase 3Terminated2026-04-15Actual
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847AARDPhase 2Completed2023-02-03Actual
Study to Evaluate ARD-101 in Adults With ObesityNCT05121441AARDPhase 2Completed2022-11-09Actual
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434AARDPhase 2Completed2024-09-24Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.